Open Access

Herbs and plants in immunomodulation (Review)

  • Authors:
    • Tanya Kadiyska
    • Ivan Tourtourikov
    • Kristiyan Dabchev
    • Alexandra Zlatarova
    • Nikolay Stoynev
    • Radka Hadjiolova
    • Demetrios A. Spandidos
    • Maria Adamaki
    • Vassilis Zoumpourlis
  • View Affiliations

  • Published online on: April 27, 2023     https://doi.org/10.3892/ijfn.2023.31
  • Article Number: 1
  • Copyright : © Kadiyska et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present review article aimed to present a focused summary of the main immunomodulatory properties of some of the most frequently used herbaceous plants either in traditional medicine or as food supplements: andrographis (Andrographis paniculata), astragalus (Astragalus propinquus/membranaceus), black cumin (Nigella sativa), cardamom (Elettaria cardamomum), purple coneflower (Echinacea), ginger (Zingiber officinale), licorice (Glycyrrhiza glabra), shiitake (Lentinula edodes) and turmeric (Curcuma longa). These plants were selected based on their popularity, accessibility as a supplement, their known effects on the immune system, and the amount of scientific research performed on their extracts and active ingredients. The present review also discusses the anti‑inflammatory, antioxidant and anti‑cancer properties of these plants in relation to their immunomodulating mode of action. In this manner, the present review aims to provide a more targeted, manageable and useful data set, that may serve as the basis for diversification, and subsequent and more detailed research on these plants and their compounds.

1. Introduction

Medicinal herbs and spices have been used throughout human history for their healing properties and their quality-of-life benefits. They have constituted the major therapeutics in ancient medicinal systems, such as traditional Chinese medicine (TCM) (1), Ayurveda (2), Kampo (Japan) and numerous others (3). The interest in medicinal plants and their extracts and multi-component drugs that include active substances of natural origin has increased exponentially over the past few decades. The rationale and main goal is the development of not only potent, but also safe therapeutic compounds that would not elicit the plethora of unwanted side-effects otherwise caused by synthetic allopathic medications. Therefore, the immunomodulating activity of numerous traditionally used herbs and spices has gained increasing attention in recent years.

The immune system is relatively complex; thus, any factors influencing the functions of the immune system may also influence other systems in the human body, such as the nervous system, endocrine system, metabolism etc. Consequently, research in this field is quite diverse, and the modulation of the immune system aims to prevent disease, as well as to identify novel targets that may serve as the basis for novel and more effective therapeutics. One of the main approaches in all traditional medicine systems for preserving health and wellbeing and at the same time preventing disease, is a healthy wholesome diet that includes a number of plant-based foods. This diet has a specific focus on herbs and spices, as these can support the healthy and balanced functioning of the immune system. In this respect, studies have indicated that diet influences the various intrinsic and extrinsic factors of the immune system (4,5).

Herbs and spices have been a staple in the natural diets of all cultures globally. They have been highly valued for their anti-inflammatory properties, particularly considering that one of the major causes for the development of disease is low-grade chronic inflammation. Taken together, there are countless inflammation-lowering plants in different parts of the globe; some of these are widely known and can be found relatively easily around the globe, including thyme, oregano, rosemary, sage, basil, mint, dill, parsley, fenugreek, clove, nutmeg, cinnamon, turmeric, tulsi, lemon grass, ginger, chili pepper, pepper and numerous others (6). A vast variety of their constituents, such as flavonoids, polysaccharides, lactones, alkaloids, diterpenoids, glycosides etc. have been reported to be responsible for the immunomodulatory and anti-inflammatory properties of these plants. Notably, some of these compounds, such as curcumin, gingerol and capsaicin, appear to inhibit one or more of the steps linking pro-inflammatory stimuli to cyclooxygenase (COX) activation (7). In addition, the activation of NF-κB, a key regulator of the production of COX-2, is associated with a variety of inflammatory diseases, including cancer, atherosclerosis, myocardial infarction, diabetes, allergies, asthma, arthritis, Crohn's disease, multiple sclerosis, Alzheimer's disease, osteoporosis, psoriasis and septic shock (8,9); in this regard, the inhibition of COX should prevent the activation of the alternative NF-κB pathway and in this manner, may reduce inflammation and related symptoms (10).

Summarizing the nutraceutical properties of such an immense variety of herbs would be an extremely difficult, if not impossible, task, for any review article. Hence, the present review concentrated on a selection of promising, yet at the same time, quite popular and widely accessible plants, such as Andrographis (Andrographis paniculata), Astragalus (Astragalus propinquus/membranaceus), black cumin (Nigella sativa), cardamom (Elettaria cardamomum), purple coneflower (Echinacea), ginger (Zingiber officinale), licorice (Glycyrrhiza glabra), shiitake (Lentinula edodes) and turmeric (Curcuma longa). These plants are often promoted as natural immune boosters in the form of nutritional supplements. The key signal transduction pathways and activation methods for each herb are illustrated in Fig. 1.

2. Andrographis (Andrographis paniculata)

Andrographis is a herbaceous plant of the Acanthaceae family, known in Europe as the ‘King of Bitters’. Traditional applications in Ayurvedic medicine and TCM, among others, vary widely and include supporting liver and gallbladder function, detoxification, digestion, immune response (through the modulation of the levels of immune cells), maintaining normal body temperature, as well as use for its antiviral, cardio protective and hepatoprotective properties (11). According to previous phytochemical studies, the aerial parts of the plant possess most of the medicinal properties and are the source for the isolation of diterpenoid lactones, which are the major phytochemical and flavonoid constituents; the roots are the source of several different compounds, such as xanthones, some noriridoids and trace/macro elements (12-14). Other researchers, using a broad variety of formulations, extracts and pure compounds, have demonstrated anti-inflammatory, immunomodulating, antioxidant, cytotoxic, anti-microbial and anti-malarial properties (15).

Various extraction methods of Andrographis paniculata have been tested, based on determining free radical scavenging of extracts using the high-performance liquid chromatography-ultraviolet mass spectrometry method and the DPPH test (16). The main antioxidant compounds in plants are known as flavonoids and phenols (17). A previous study concluded that an aqueous extract has a higher concentration of total flavonoids compared to an ethanol extract, and a radical scavenging activity of 66.8 vs. 57.8% in ethanol; however, the ethanol extract appears to have more phenols compared to the aqueous extract, even though the potency of the aqueous extract is higher in antioxidant activities (16). Several phytochemicals, extracted from the leaves of Andrographis (namely andrographolide, neoandrographolide, isoandrographolide, andrograpanin, 7-O-methyl-wogonin, 14-deoxy-11,12-didehydroandro-grapholide and skullcapflavone) have been examined for their anti-inflammatory and anti-allergic effects in vitro (18,19). The majority of these compounds have been shown to induce a concentration-dependent inhibition of the release of inflammatory mediators from cultured macrophages, stimulated by lipopolysaccharides (LPS), such as nitric oxide (NO) and prostaglandin E2, interleukin (IL)-1β and IL-6. The compound with the broadest effect appeared to be andrographolide, whereas 7-O-methylwogonin was unique in its potent dose-dependent ability to inhibit A23187-induced (calcimycin-stimulated) histamine release in RBL-2H3 rat basophil leukemic cells (18). In a previous study, andrographolide, dehydroandrographolide and neo-andrographolide were shown to exhibit anti-inflammatory effects by interfering with both COX-1 and COX-2 enzyme activity (20). Dehydroandrographolide demonstrated the highest efficacy in modulating the level of LPS-induced TNF-α, IL-6, IL-1β and IL-10 secretion in human blood, in a concentration-dependent manner; its mechanism of action may be related to the downregulation of the expression of genes involved in the inflammatory cascade (20), as research using mice has demonstrated that dehydroandrographolide can inhibit NF-κB activation in mice (21). The diterpenes, andrographolide and neoandrographolide, have been shown to induce significant antibody responses in mice, delayed hypersensitivity response against sheep red blood cells, as well as non-specific immune responses (22). When ethanol extract was applied instead of purified diterpenes, an immune response was still observed, albeit considerably milder, suggesting that other constituents in the alcohol extract may provide an entourage immunostimulating effect (22).

Further studies investigating the mechanisms of action are expected to contribute towards an improved assessment and understanding of the complex pharmacological effects of this plant. In addition, safety should be evaluated through laboratory and clinical studies on the toxicity of the different extracts and certain pure phytochemical isolates.

3. Astragalus (Astragalus propinquus/membranaseus)

Astragalus is a leguminous plant and its main chemical composition includes astragaloside, Astragalus polysaccharide (APS), astragalus flavonoids, selenium and other trace elements (23). In TCM, where it is known as Huangqi, it is used both as a medicine and food; it is believed to stimulate the spleen and to replenish the vital energy that is considered to circulate the body in currents, also known as the qi (23). Astragalus is used to treat weakness, wounds, anemia, fever, multiple allergies, chronic fatigue, loss of appetite, uterine bleeding and prolapse (24). The main pharmacologically active ingredient is APS, a type of water-soluble heteropolysaccharide extracted from the stems or dried roots (25). APS exerts multiple bioactive effects, several of which have been thoroughly investigated, particularly for their activity in immune regulation and anti-aging. APS has further gained attention due to its ability to reduce blood sugar levels and lower blood lipid levels, as well as due to its antitumor, anti-fibrotic, antibacterial and antiviral effects, and its radiation shielding properties (23). As regards immunomodulation, APS has been shown to activate mouse macrophages and B-cells, rather than T-cells, leading to proliferation and cytokine production via the activation of Toll-like receptor (TLR)4(1). It has also been reported to inhibit the growth of the breast cancer cell line, MDA-MB-468(26). Xu et al (27) demonstrated that APS strongly promoted the phagocytosis of Mycobacterium tuberculosis and the secretion of IL-1α, IL-6 and TNF-α by activated macrophages. Experimental data have also indicated that this particular polysaccharide can initiate splenocytes to secrete IL-2, IL-3, IL-4 and IL-6, and also induce interferon (IFN) production (23), with substantial evidence also pointing towards a concentration-dependent initiation of IL-10, IL-12 and IL-2 secretion (28). Furthermore, in carp models, APS has been shown to increase the levels of IL1-β, lysozyme C and TNF-α in the kidneys, gills and spleen, in a dose-dependent manner (29). Various experiments using H22 tumor-bearing mice have also demonstrated that the administration of APS increases the production of IL2, IL6 and TNF-α, which further highlights the effects of APS on the immune system and subsequently, its antitumor activity (30,31).

Several preclinical studies and clinical trials have demonstrated that Astragalus has more potent anticancer effects than immunomodulatory properties (32-34) and for this reason, it is recommended to cancer patients as a complementary and alternative therapy (35). Nonetheless, it has also exhibited immense potential in balancing Treg/Th17 cells, and is thus being investigated as a potential complementary treatment for patients with asthma (36) and perhaps for patients with diabetic nephropathy (37).

4. Black cumin (Nigella sativa)

Black cumin, also known as Nigella sativa, is a widely used medicinal plant of the Ranunculaceae family. Its popularity encompasses almost all traditional medicinal systems, such as Indian, Ayurveda and Siddha, Islamic Tibb-e-Nabawi and Western herbalism. In Bulgarian folklore, it is referred to as ‘the herb that cures everything but death’. Black cumin has been broadly used as a (skin) tonic, a digestive, an anti-diarrheal, an appetite stimulant, an anti-bacterial, an antihypertensive, a diuretic and an analgesic. The majority of its therapeutic effects are considered to be due to thymoquinone (TQ), a major bioactive component of black cumin essential oil (38).

In vitro studies have demonstrated that the aqueous extract of black cumin exerts an anti-inflammatory and immunomodulatory effect, as it significantly enhances splenocyte proliferation in BLAB/c mice and C57/BL6 primary cells in a concentration-dependent manner (39). Specifically, the aqueous extract appears to favor the secretion of Th2, as opposed to Th1 cytokines by splenocytes; the secretion of key pro-inflammatory mediators, such as IL-6, TNF-α and NO by macrophages is significantly suppressed and the cytotoxic activity of natural killer (NK) cells against YAC-1 tumor cells is significantly enhanced (40). This suggests that black cumin bioactive compounds may be used as therapeutic agents for the regulation of several immune reactions in variety of conditions and diseases, such as cancer (40). In addition, the immunomodulatory activity of black cumin seed can be used for the prophylaxys of opportunistic infections and as adjuvant treatment in certain oncological patients (39). Other observations indicate that the seeds of Nigella sativa may represent a potential immunosuppressive cytotoxic agent (41). Preventative oral administration of N. sativa oil to rats daily has been shown to significantly reverse the reduction of hemolysin antibody titers related to the applied whole body gamma irradiation (42). This suggests that the oil may constitute a promising radioprotective agent against ionizing radiation, particularly against the immunosuppressive and oxidative effects of the latter (42).

Both the aqueous and alcoholic extracts of black cumin exhibit anti-inflammatory and analgesic properties, which are considered to be exerted by their TQ content. The concentration of the latter varies greatly throughout the different parts of the plant; it is 12-fold higher in the leaf callus than the seed extract. The anti-inflammatory effects of TQ on inflamed rat mix glial cells is evidenced by a significant reduction in NO production (43). In addition, oxidative stress and inflammation related to osteoporosis appear to be beneficially influenced by TQ via the inhibition of inflammatory cytokine production, such as IL-1 and IL-6, and the element of the NF-κB consensus site (44). It also appears to reduce the synthesis of monocyte chemoattractant protein (MCP)-1, TNF-α, IL-1β and COX-2 by pancreatic ductal adenocarcinoma cells in a concentration- and time-dependent manner. These results suggest that TQ may be a promising agent that combines the inhibition of proinflammatory pathways with a pro-apoptotic mode of action (45). Other researchers have also demonstrated the anti-inflammatory effects of TQ during an allergic response in the lungs, through the inhibition of prostaglandin D2 synthesis and Th2-driven immune responses (46).

Last but not least, a clinical trial was conducted as a prospective and double-blind study with descriptive analysis to investigate the anti-inflammatory effects of Nigella sativa in patients with allergic rhinitis (47). The results revealed that Nigella sativa reduced the congestion of the nasal mucosa, itching, mucosal pallor, runny nose and sneezing attacks, thereby suggesting that it may be beneficial as a treatment option when other anti-allergic drugs must be avoided for various reasons (47).

5. Cardamom (Elettaria cardamomum)

Cardamom is a traditional aromatic plant from the family of Zingiberaceae. The chemical composition of cardamom varies, depending on its origin and maturity stage. The seed contains 2 to 5% of the volatile compounds that contribute to the sweet and spicy flavor. The essential oil contains a considerable number of bioactive compounds, such as α-pinene, α-phellandrene, β-pinene, myrcene, limonene, sabinene, 1,8-cineole, linalool, terpinolene, γ-terpinene, linalyl acetate, α-terpineol, terpinen 4-ol, α-terpinyl acetate, geraniol, citronellol, trans-nerolidol and methyl eugenol (48). The particular flavor of cardamom is mainly owned by α-terpinyl acetate and 1,8-cineole (19). Over the years, cardamom has been used in the treatment of disorders, such as asthma, indigestion and congestive jaundice (49).

It has been demonstrated that cardamom possesses various pharmacological properties, such as antioxidant, anti-inflammatory, anticancer and antimicrobial properties (48). The aqueous extract exerts immunomodulatory effects as well, which have been validated in vivo. In particular, it has been shown to significantly enhance splenocyte proliferation in a synergistic and concentration-dependent manner; based on an enzyme-linked immunosorbent assay, cardamom was shown to significantly inhibit the release of Th1-cytokines from splenocytes and to enhance Th2-cytokine release (50). Previous research has indicated that cardamom extract exerts anti-inflammatory effects in BALB/c mice, as it significantly enhances the cytotoxic activity of NK cells, thereby indicating an anticancer potential (50). Additional research has demonstrated that cardamom modulates the status of proliferation, and the modification of COX-2 and inducible nitric oxide synthase (iNOS) expression in apoptotic processes, suggesting that it may confer a protective effect in experimentally-induced colon carcinogenesis (51).

6. Echinacea

Echinacea belongs to a genus of herbaceous flowering plants, commonly known as coneflowers, with Echinacea purpurea being the herb most commonly used either to treat or prevent the common cold, despite the existence of contradictory data regarding its efficacy. For example, a 2014 systematic review claimed that Echinacea was ineffective against the common cold (51), whereas a subsequent meta-analysis found some evidence that it reduces the risk of repetitive respiratory infections (52,53).

Three species of Echinacea are widely used medicinally: E. purpurea, E. angustifolia, and E. pallida (54). Preparations of the root and aerial parts of the three species are all currently being promoted as immune stimulants (55). The immune-boosting effects of Echinacea are considered to result primarily through the targeting of non-specific immune mechanisms, including phagocytic activity, macrophage activation and NK cell activity. These effects have been demonstrated in vitro, where both the juice from the aerial part of E. purpurea and alcohol extracts from roots of E. purpurea, E. angustifolia and E. pallida have been used (56,57). In macrophages, phagocytosis and cytokine production (evidenced as increased levels of TNF-α, IL-1 and IFN-β) appear to be enhanced following treatment with Echinacea extracts (58). Increased leukocyte mobility and the activation of NK cells has also been reasonably demonstrated in animals and humans (58-61). Notably, E. purpurea polysaccharide-enriched extracts can promote the phenotypic and functional maturation of dendritic cells via the modulation of the JNK, p38 MAPK and NF-κB pathways (62). In addition, Fu et al (63) demonstrated that Echinacea extract was a potent activator of murine bone marrow-derived macrophages by increasing the expression of CD80, CD86 and MHCII molecules, and by upregulating the levels of markers of classically activated macrophages (M1), including CCR7, and the production of IL-1β, IL-6, IL-12p70, TNF-α and NO.

There are still open questions related to the long-term use of Echinacea. Although primarily considered for therapeutic purposes, some authors suggest the use of Echinacea as a prophylactic during winter (64). The long-term effects of Echinacea (in years) are unknown.

7. Ginger (Zingiber officinale)

Ginger (Zingiber officinale Rosc.) belongs to the family of Zingiberaceae. It has long been cultivated as a flavoring spice to Indian food (65) and is generally widely used in South East Asia. The constituents of ginger are numerous and vary, depending on the place of origin and form of rhizomes, e.g., fresh or dry. The ginger rhizome contains multiple compounds of interest, such as carbohydrates, minerals, phytochemicals, phenolic compounds, terpenes, polysaccharides, lipids, organic acids, and raw fibers (66). It also contains appreciable amounts of vitamins and minerals and some enzymes, among which the potent proteolytic enzyme, zingibain, appears to be of particular interest (67). Ginger contains >40 antioxidant compounds, which can be used to treat various inflammatory conditions (68).

Ginger, being both a traditional spice and medicine in TCM and Ayurveda, is also consumed in various forms in order to boost immunity, reduce nausea and to ease digestion, as evidenced by several clinical trials, while the dietary supplementation of the powdered rhizome (vertical root) daily may increase testosterone levels (69,70). As regards immune function, ginger has been shown to successfully lower TNF-α and IL-1β levels compared to placebo in patients knee osteoarthritis, where pain is caused by joint inflammation due to the overproduction of synovial cytokines; this demonstrates its ability to modulate inflammatory cytokine production in chronic disease (71). The structurally related substances, gingerol and shogaol in ginger inhibit prostaglandins by preventing the biosynthesis of prostaglandin synthase, and may also be effective against arachidonate 5-lipoxygenase, which is part of the leukotriene biosynthesis (2). Overall, ginger is believed to inhibit the synthesis of IL-1, TNF-α and IL-8, acting in a pro-inflammatory cytokine manner, through a mechanism that includes influencing of coding genes (72,73). In another study, [6]-shogaol was shown to downregulate inflammatory iNOS levels by inhibiting the expression of the COX-2 gene in macrophages, and the activation of NF-κB by disrupting the activation PI3K/Akt/IκB-kinases IKK and MAPK (74).

8. Liquorice (Glycyrrhiza glabra)

Liquorice (or licorice) is a plant of the family Fabaceae (Glycyrrhiza glabra L.). The use of licorice is well described and already has a history of several thousands of years. The plant has been implemented in TCM and medieval medicine as a tonic, to promote vitality, and to treat ulcers, gastritis, a variety of infections and other inflammatory conditions. The most significant compounds in terms of pharmacological activity include flavonoids, triterpenes and saponins, where the main bioactive compound is glycyrrhizin (5-24%) (75). The composition varies greatly depending on the species, geographical location and environmental conditions, with the species growing in Iran, China and Russia having the highest glycyrrhizin contents (76).

Licorice polysaccharides have demonstrated a potential immunomodulatory and anticancer effect in mice, by inducing and upregulating the expression of IL-7, an antitumor cytokine, as well as by affecting T-lymphocytes (77). Glycyrrhizin, glabridin and isoliquiritigenin have exhibited apoptotic and anti-proliferative activity on cancer cells in vitro (78,79). Similarly, 18β-glycyrrhetinic acid, has exhibited immunomodulatory activity by enhancing T-cell proliferation, thereby increasing leukocyte concentration in murine models (80). The polyphenols of licorice induce apoptosis by upregulating the expression of Bax and Bid proteins and via the downregulation of Bcl-2, thus affecting the caspase pathway (81).

In 4T1 murine mammary cancer cells, licorice has been observed to inhibit and attenuate the progression of angiogenesis and metastasis of cancer cells, by reducing inflammation and tumor growth (82,83). The introduction of licorice compounds as adjuvant treatment in chemotherapy has demonstrated increased anticancer activity and hepatoprotection in murine models (84,85). Furthermore, licorice appears to downregulate the levels of the inflammatory cytokines, IL-6, IL-1 and TNFα in vitro (86). Such observations highlight the promising activity of licorice compounds in vitro, and undoubtedly warrant their testing in clinical trials to determine their safety and efficacy in various clinical settings.

9. Shiitake (Lentinula edodes)

Shiitake is a type of mushroom that grows on the Shii tree [Castanopsis cuspidata (Thunb.) Schottky]. It is well known as a dense, nutrient-rich food, and as a medicine for thousands of years (3,87). The mushroom has been proven to exert anticarcinogenic, antitumor, hepatoprotective, cardiovascular and immunomodulating effects. It also has antibacterial and antiviral properties and has been found to be a potent antioxidant (88). The chemical composition of the Shiitake mushroom consists of ~58-60% carbohydrates, 20-23% protein (with 80-87% digestibility), 9-10% fiber and 3-4% lipids (89). It is also an excellent source of vitamins, including D2 and B 1, 2, 5 and 12. In addition, Shiitake contains a plethora of minerals, namely zinc, copper, phosphorus, manganese, iron, potassium, calcium, magnesium and cadmium (87).

The antitumor polysaccharide, lentinan (LNT), a β-d-glucan, is regarded to be the most significant of the medicinal properties of the Shiitake mushroom; LNT forms a worm-like triple helix, that is heat-stable, water-soluble and alkali labile (90). However, due to limitations in 3D structure identification technology and crystal structure absence, there is still no detailed structure information of lentinan (91). Studies have suggested that LNT can cause the regression of solid type tumors of sarcoma 180 almost completely, as well as several other tumors, including methylcholanthrene-induced fibrosarcoma (92,93). It was later shown that the antitumor activity also affects synergic and autochthonous tumors and prevents viral and chemical oncogenesis (94). Overall, it has been demonstrated that β-glucans can serve as pathogen-associated molecular patterns, initiating immune responses through the binding of pattern recognition receptors, such as dectin-1, TLR2/4/6 and CR3(95). Among, these, dectin-1 appears to be of the highest significance, as it constitutes a cell-like-receptor type II membrane protein, expressed in variety of cells, but mainly in neutrophils, dendritic cells and macrophages (96). The binding of LNT to these receptors leads to the activation of MAPK/NF-κB and spleen tyrosine kinase (Syk)/protein kinase C signaling (97). Following this, T-lymphocytes upregulate the expression of TNF-α, TLR4 and TLR9, whereas B-lymphocytes secrete IgG and enhance macrophage activity in mice (98). Additional activities of LNT include NK cell activation and an increased production of IFN-γ and IL-12(99). These findings strongly suggest that lentinan and similar polysaccharides have key immunomodulatory properties and can be used to supplement ongoing treatment in a variety of cancerous diseases and tumors.

10. Turmeric (Curcuma longa)

Curcumin is a yellow polyphenolic pigment from the Curcuma longa L. (turmeric) rhizome, a flowering plant of the ginger family. It has been used throughout history for culinary and medicinal purposes, specifically in Ayurvedic and Chinese medicine. The use of the spice dates ~5,000 years back in history (100). Apart from its use as a culinary seasoning, turmeric has been historically used as an antimicrobial agent, an insect repellent and a natural coloring agent (101). Curcumin, demethoxycurcumin and bisdemethoxycurcumin are bioactive polyphenolic compounds, identified in turmeric, which have been collectively referred to as curcuminoids (CCMs) (4). It can be safely ingested in very high doses, as confirmed by several clinical studies (102).

The chemical composition of turmeric consists of ~70% carbohydrates, 6% proteins, 6% essential oils (phellandrene, sabinene, cineol, borneol, zingiberene and sesquiterpenes), 5% fat, 3% minerals (potassium, calcium, phosphorus, iron and sodium), 3-5% curcuminoids, and trace amounts of vitamins (B1, B2, C and niacin) (103,104). One of extensively researched effects of curcumin on inflammation is the inhibition of the TNF-α-induced activation and nuclear translocation of NF-κB (105). It also appears to exert inhibitory effects on several inflammatory cytokines, such as IL-1β, IL-2, IL-5, IL-6, IL-8, IL-12 and IL18(106). Other activities include the downregulation of monocytes via MCP-1, and macrophage recruitment via macrophage inflammatory protein-1 α (107). Curcumin can also suppress the activity of protein kinases, including protein kinase A, phosphorylase kinase, mTOR and MAPKs, which play essential roles in various cellular responses, including the regulation of cell growth, proliferation, division, survival and death (103). Although curcumin lacks analgesic and antipyretic properties (106), the suppression of inflammation is a vital therapeutic effect.

Overall, curcumin is well-tolerated and has multiple beneficial effects; however, it has a low bioavailability which is a main obstacle to its application as a therapeutic agent (109). Nonetheless, adding piperine, an alkaloid present in black pepper (Piper nigrum), to the curcumin compound appears to increase its bioavailability by 2,000%, which allows for a highly improved therapeutic effect (110).

11. Conclusions and future perspectives

The present general overview of the few selected, very broadly promoted and highly popular immunomodulatory herbs (Fig. 2 and Table I), clearly demonstrates that all plants have very promising profiles as preventative tools in a general naturopathic setting, and most likely, in the therapy setting as well. It is evident however, that there is still a long way to go before consistent data can be collected, that is easily applicable and reliable. At present, the available information in the scientific literature is relatively scattered and inconsistent. A broad variety of approaches have been applied to study each one of the different herbs and for this reason, the data cannot be easily summarized and processed. For some herbs, the main focus is on phytochemical constituent research, combined with some in vitro data regarding the application of various extracts on a broad spectrum of models, such as cell cultures, research animals, etc. (111). For other herbs, there is a comparison between the effects of single-isolated and purified compounds and some water-based or alcohol-based extracts (112). It is not very clear, however, what will occur when whole extracts are applied, or which of the pharmacologically active constituents play the major role in the observed effect. Presumably, the entourage effect is much more significant in terms of conferring a therapeutic benefit rather than the effect of purified single compounds. Furthermore, whole extracts may have a much safer profile. As such, a considerable amount of research is required to provide ample evidence.

Table I

Summary of the names, active ingredients and chemical formulas of the included herbs and plants.

Table I

Summary of the names, active ingredients and chemical formulas of the included herbs and plants.

Plant nameMain active ingredientChemical formula(Refs.)
Andrographis (Andrographis paniculata) Andrographolide C20H30O5(15,16)
Astragalus (Astragalus propinquus/membranaseus)Astragaloside, Astragalus polysaccharide C28H32O17(22)
Black cumin (Nigella sativa)Thymoquinone C10H12O2(38)
Cardamom (Elettaria cardamomum)Terpinyl acetate, 1,8-cineole C12H20O2, C10H18O(48)
EchinaceaAlkamides, caffeic acid derivatives C9H8O4(54)
Ginger (Zingiber officinale)Gingerol, shogaol C17H26O4, C17H24O3(67)
Liquorice (Glycyrrhiza glabra)Glycyrrhizin, other polysaccharides C42H62O16(76)
Shiitake (Lentinula edodes)Lentinan, other β-glucans C42H72O36(87)
Turmeric (Curcuma longa)Turmeric C21H20O6(104)

In addition, the available data on safety (the majority of data have been obtained via hepatocyte culture models) are not sufficient (5,113-115). Human clinical data are even more limited. There is partial information from some prospective observational trials; however, double-blinded, randomized, placebo-controlled trials (which are the golden standard) are lacking. Adequate research on all of these promising plants, even the few that were selected for discussion in the present review, would require a very consistent and structured approach, numerous resources invested in terms of time and funding, and more importantly, a good collaboration between research teams. However, despite all these visible hurdles, it can be considered that plant-based therapeutics represent a very promising area of pharmacological research and development, which may prove to be effective, both in terms of patient well-being and therapeutics, and in terms of industry profits.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

Not applicable.

Authors' contributions

IT, KD and AZ performed the initial collection and curation of the data to be included in the review. AZ, NS, RH and TK reviewed the collected data and extracted relevant information. IT, KD, TK, AZ and NS summarized the data for each presented example. DAS, RH, MA and VZ reviewed and edited the manuscript. All authors have read and approved the final version of the manuscript. Data authentication is not applicable.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

DAS is the Honorary Editor of the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating on the final decision, for this article. The other authors declare that they have competing interests.

References

1 

Shao BM, Xu W, Dai H, Tu P, Li Z and Gao XM: A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun. 320:1103–1111. 2004.PubMed/NCBI View Article : Google Scholar

2 

Azeez TB and Lunghar J: 6-Antiinflammatory effects of turmeric (Curcuma longa) and ginger (Zingiber officinale). In: Gopi S, Amalraj A, Kunnumakkara A and Thomas S (eds). Inflammation and Natural Products. Academic Press, pp127-146, 2021.

3 

Rahman T and Choudhury MBK: Shiitake mushroom: A tool of medicine. Bangladesh J Med Biochem. 5:24–32. 2012.

4 

Isbill J, Kandiah J and Kružliaková N: Opportunities for health promotion: Highlighting herbs and spices to improve immune support and well-being. Integr Med (Encinitas). 19:30–42. 2020.PubMed/NCBI

5 

Pelvan E, Karaoğlu Ö, Önder Fırat E, Betül Kalyon K, Ros E and Alasalvar C: Immunomodulatory effects of selected medicinal herbs and their essential oils: A comprehensive review. J Funct Foods. 94(105108)2022.

6 

Rubió L, Motilva MJ and Romero MP: Recent advances in biologically active compounds in herbs and spices: A review of the most effective antioxidant and anti-inflammatory active principles. Crit Rev Food Sci Nutr. 53:943–953. 2013.PubMed/NCBI View Article : Google Scholar

7 

Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, et al: Health benefits of herbs and spices: The past, The present, the future. Med J Aust. 185 (S4):S1–S24. 2006.PubMed/NCBI View Article : Google Scholar

8 

Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 71:1397–1421. 2006.PubMed/NCBI View Article : Google Scholar

9 

Lim JW, Kim H and Kim KH: Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab Invest. 81:349–360. 2001.PubMed/NCBI View Article : Google Scholar

10 

Shi G and Li D, Fu J, Sun Y, Li Y, Qu R, Jin X and Li D: Upregulation of cyclooxygenase-2 is associated with activation of the alternative nuclear factor kappa B signaling pathway in colonic adenocarcinoma. Am J Transl Res. 7:1612–1620. 2015.PubMed/NCBI

11 

Kishore V, Yarla NS, Bishayee A, Putta S, Malla R, Neelapu NRR, Challa S, Das S, Shiralgi Y, Hegde G and Dhananjaya BL: Multi-targeting andrographolide and its natural analogs as potential therapeutic agents. Curr Top Med Chem. 17:845–857. 2017.PubMed/NCBI View Article : Google Scholar

12 

Xu C, Chou GX, Wang CH and Wang ZT: Rare noriridoids from the roots of Andrographis paniculata. Phytochemistry. 77:275–279. 2012.PubMed/NCBI View Article : Google Scholar

13 

Behera PR, Nayak P, Barik DP, Rautray TR, Thirunavoukkarasu M and Chand PK: ED-XRF spectrometric analysis of comparative elemental composition of in vivo and in vitro roots of Andrographis paniculata (Burm.f.) Wall. ex Nees-a multi-medicinal herb. Appl Radiat Isot. 68:2229–2236. 2010.PubMed/NCBI View Article : Google Scholar

14 

Okhuarobo A, Falodun JE, Erharuyi O, Imieje V, Falodun A and Langer P: Harnessing the medicinal properties of Andrographis paniculata for diseases and beyond: A review of its phytochemistry and pharmacology. Asian Pac J Trop Dis. 4:213–222. 2014.

15 

Li X, Yuan W, Wu J, Zhen J, Sun Q and Yu M: Andrographolide, a natural anti-inflammatory agent: An update. Front Pharmacol. 13(920435)2022.PubMed/NCBI View Article : Google Scholar

16 

Zhao Y, Kao CP, Wu KC, Liao CR, Ho YL and Chang YS: Chemical compositions, chromatographic fingerprints and antioxidant activities of andrographis herba. Molecules. 19:18332–18350. 2014.PubMed/NCBI View Article : Google Scholar

17 

Mussard E, Cesaro A, Lespessailles E, Legrain B, Berteina-Raboin S and Toumi H: Andrographolide, a natural antioxidant: An update. Antioxidants (Basel). 8(571)2019.PubMed/NCBI View Article : Google Scholar

18 

Chandrasekaran CV, Thiyagarajan P, Deepak HB and Agarwal A: In vitro modulation of LPS/calcimycin induced inflammatory and allergic mediators by pure compounds of Andrographis paniculata (King of bitters) extract. Int Immunopharmacol. 11:79–84. 2011.PubMed/NCBI View Article : Google Scholar

19 

Choi MJ and Kim YR: Anti-allergic effect of fermented extracts of medicinal plants andrographis paniculate, salvia plebeia R. Br., canavalia gladiate, eleuthorococcus senticosus, ulmus davidiana var. japonica, and clerodendrum trichotomum thunb. ex murray. Microbiol Biotechnol Lett. 50:512–521. 2022.

20 

Parichatikanond W, Suthisisang C, Dhepakson P and Herunsalee A: Study of anti-inflammatory activities of the pure compounds from Andrographis paniculata (burm.f.) Nees and their effects on gene expression. Int Immunopharmacol. 10:1361–1373. 2010.PubMed/NCBI View Article : Google Scholar

21 

Weng Z, Chi Y, Xie J, Liu X, Hu J, Yang F and Li L: Anti-inflammatory activity of dehydroandrographolide by TLR4/NF-κB signaling pathway inhibition in bile duct-ligated mice. Cell Physiol Biochem. 49:1124–1137. 2018.PubMed/NCBI View Article : Google Scholar

22 

Puri A, Saxena R, Saxena RP, Saxena KC, Srivastava V and Tandon JS: Immunostimulant agents from Andrographis paniculata. J Nat Prod. 56:995–999. 1993.PubMed/NCBI View Article : Google Scholar

23 

Zheng Y, Ren W, Zhang L, Zhang Y, Liu D and Liu Y: A review of the pharmacological action of Astragalus polysaccharide. Front Pharmacol. 11(349)2020.PubMed/NCBI View Article : Google Scholar

24 

Kim C, Ha H, Kim JS, Kim YT, Kwon SC and Park SW: Induction of growth hormone by the roots of Astragalus membranaceus in pituitary cell culture. Arch Pharm Res. 26:34–39. 2003.PubMed/NCBI View Article : Google Scholar

25 

Han J, Guo D, Sun XY, Wang JM, Ouyang JM and Gui BS: Repair effects of Astragalus polysaccharides with different molecular weights on oxidatively damaged HK-2 cells. Sci Rep. 9(9871)2019.PubMed/NCBI View Article : Google Scholar

26 

Ye MN, Chen HF, Zhou RJ and Liao MJ: Effects of Astragalus polysaccharide on proliferation and Akt phosphorylation of the basal-like breast cancer cell line. Zhong Xi Yi Jie He Xue Bao. 9:1339–1346. 2011.PubMed/NCBI View Article : Google Scholar : (In Chinese).

27 

Xu HD, You CG, Zhang RL, Gao P and Wang ZR: Effects of Astragalus polysaccharides and astragalosides on the phagocytosis of Mycobacterium tuberculosis by macrophages. J Int Med Res. 35:84–90. 2007.PubMed/NCBI View Article : Google Scholar

28 

Yin JY, Chan BCL, Yu H, Lau IYK, Han XQ, Cheng SW, Wong CK, Lau CB, Xie MY, Fung KP, et al: Separation, structure characterization, conformation and immunomodulating effect of a hyperbranched heteroglycan from radix astragali. Carbohydr Polym. 87:667–675. 2012.PubMed/NCBI View Article : Google Scholar

29 

Yuan C, Pan X, Gong Y, Xia A, Wu G, Tang J and Han X: Effects of Astragalus polysaccharides (APS) on the expression of immune response genes in head kidney, gill and spleen of the common carp, Cyprinus carpio L. Int Immunopharmacol. 8:51–58. 2008.PubMed/NCBI View Article : Google Scholar

30 

Tian QE, Li HD, Yan M, Cai HL, Tan QY and Zhang WY: Astragalus polysaccharides can regulate cytokine and P-glycoprotein expression in H22 tumor-bearing mice. World J Gastroenterol. 18:7079–7086. 2012.PubMed/NCBI View Article : Google Scholar

31 

Yang B, Xiao B and Sun T: Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice. Int J Biol Macromol. 62:287–290. 2013.PubMed/NCBI View Article : Google Scholar

32 

Balakrishnan B, Liang Q, Fenix K, Tamang B, Hauben E, Ma L and Zhang W: Combining the anticancer and immunomodulatory effects of Astragalus and shiitake as an integrated therapeutic approach. Nutrients. 13(2564)2021.PubMed/NCBI View Article : Google Scholar

33 

Liu ZG, Xiong ZM and Yu XY: Effect of astragalus injection on immune function in patients with congestive heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi. 23:351–353. 2003.PubMed/NCBI(In Chinese).

34 

Li S, Sun Y, Huang J, Wang B, Gong Y, Fang Y, Liu Y, Wang S, Guo Y, Wang H, et al: Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation: Status and prospect. J Ethnopharmacol. 258(112797)2020.PubMed/NCBI View Article : Google Scholar

35 

Zhou L, Liu Z, Wang Z, Yu S, Long T, Zhou X and Bao Y: Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo. Sci Rep. 7(44822)2017.PubMed/NCBI View Article : Google Scholar

36 

Wang W, Liu QB and Jing W: Astragalus membranaceus improves therapeutic efficacy of asthmatic children by regulating the balance of Treg/Th17 cells. Chin J Nat Med. 17:252–263. 2019.PubMed/NCBI View Article : Google Scholar

37 

Li M, Wang W, Xue J, Gu Y and Lin S: Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. J Ethnopharmacol. 133:412–419. 2011.PubMed/NCBI View Article : Google Scholar

38 

Fatima Shad K, Soubra W and Cordato DJ: The role of thymoquinone, a major constituent of Nigella sativa, in the treatment of inflammatory and infectious diseases. Clin Exp Pharmacol Physiol. 48:1445–1453. 2021.PubMed/NCBI View Article : Google Scholar

39 

Ghonime M, Eldomany R, Abdelaziz A and Soliman H: Evaluation of immunomodulatory effect of three herbal plants growing in Egypt. Immunopharmacol Immunotoxicol. 33:141–145. 2011.PubMed/NCBI View Article : Google Scholar

40 

Majdalawieh AF, Hmaidan R and Carr RI: Nigella sativa modulates splenocyte proliferation, Th1/Th2 cytokine profile, macrophage function and NK anti-tumor activity. J Ethnopharmacol. 131:268–275. 2010.PubMed/NCBI View Article : Google Scholar

41 

Torres MP, Ponnusamy MP, Chakraborty S, Smith LM, Das S, Arafat HA and Batra SK: Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: Implications for the development of novel cancer therapies. Mol Cancer Ther. 9:1419–1431. 2010.PubMed/NCBI View Article : Google Scholar

42 

Assayed ME: Radioprotective effects of black seed (Nigella sativa) oil against hemopoietic damage and immunosuppression in gamma-irradiated rats. Immunopharmacol Immunotoxicol. 32:284–296. 2010.PubMed/NCBI View Article : Google Scholar

43 

Alemi M, Sabouni F, Sanjarian F, Haghbeen K and Ansari S: Anti-inflammatory effect of seeds and callus of Nigella sativa L. extracts on mix glial cells with regard to their thymoquinone content. AAPS PharmSciTech. 14:160–167. 2013.PubMed/NCBI View Article : Google Scholar

44 

Shuid AN, Mohamed N, Mohamed IN, Othman F, Suhaimi F, Mohd Ramli ES, Muhammad N and Soelaiman IN: Nigella sativa: A potential antiosteoporotic agent. Evid Based Complement Alternat Med. 2012(696230)2012.PubMed/NCBI View Article : Google Scholar

45 

Chehl N, Chipitsyna G, Gong Q, Yeo CJ and Arafat HA: Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford). 11:373–381. 2009.PubMed/NCBI View Article : Google Scholar

46 

El Mezayen R, El Gazzar M, Nicolls MR, Marecki JC, Dreskin SC and Nomiyama H: Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. Immunol Lett. 106:72–81. 2006.PubMed/NCBI View Article : Google Scholar

47 

Nikakhlagh S, Rahim F, Aryani FHN, Syahpoush A, Brougerdnya MG and Saki N: Herbal treatment of allergic rhinitis: The use of Nigella sativa. Am J Otolaryngol. 32:402–407. 2011.PubMed/NCBI View Article : Google Scholar

48 

Souissi M, Azelmat J, Chaieb K and Grenier D: Antibacterial and anti-inflammatory activities of cardamom (Elettaria cardamomum) extracts: Potential therapeutic benefits for periodontal infections. Anaerobe. 61(102089)2020.PubMed/NCBI View Article : Google Scholar

49 

Jamal A, Siddiqui A, Aslam M, Javed K and Jafri MA: Antiulcerogenic activity of Elettaria cardamomum maton. and amomum subulatum Roxb. Seeds. Indian J Tradit Knowl. 4:298–302. 2005.

50 

Majdalawieh AF and Carr RI: In Vitro Investigation of the potential immunomodulatory and anti-cancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum). J Med Food. 13:371–381. 2010.PubMed/NCBI View Article : Google Scholar

51 

Sengupta A, Ghosh S and Bhattacharjee S: Dietary cardamom inhibits the formation of azoxymethane-induced aberrant crypt foci in mice and reduces COX-2 and iNOS expression in the colon. Asian Pac J Cancer Prev. 6:118–122. 2005.PubMed/NCBI

52 

Karsch-Völk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K and Linde K: Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2014(CD000530)2014.PubMed/NCBI View Article : Google Scholar

53 

Schapowal A, Klein P and Johnston SL: Echinacea reduces the risk of recurrent respiratory tract infections and complications: A meta-analysis of randomized controlled trials. Adv Ther. 32:187–200. 2015.PubMed/NCBI View Article : Google Scholar

54 

Manayi A, Vazirian M and Saeidnia S: Echinacea purpurea: Pharmacology, phytochemistry and analysis methods. Pharmacogn Rev. 9:63–72. 2015.PubMed/NCBI View Article : Google Scholar

55 

Block KI and Mead MN: Immune system effects of Echinacea, ginseng, and astragalus: A review. Integr Cancer Ther. 2:247–267. 2003.PubMed/NCBI View Article : Google Scholar

56 

Bauer R: Echinacea drugs-effects and active ingredients. Z Arztl Fortbild (Jena). 90:111–115. 1996.PubMed/NCBI(In German).

57 

Coeugniet EG and Elek E: Immunomodulation with Viscum album and Echinacea purpurea extracts. Onkologie. 10 (3 Suppl):S27–S33. 1987.PubMed/NCBI View Article : Google Scholar

58 

McCann DA, Solco A, Liu Y, Macaluso F, Murphy PA, Kohut ML and Senchina DS: Cytokine- and interferon-modulating properties of Echinacea spp. root tinctures stored at -20 degrees C for 2 years. J Interferon Cytokine Res. 27:425–436. 2007.PubMed/NCBI View Article : Google Scholar

59 

Percival SS: Use of Echinacea in medicine. Biochem Pharmacol. 60:155–158. 2000.PubMed/NCBI View Article : Google Scholar

60 

Luettig B, Steinmüller C, Gifford GE, Wagner H and Lohmann-Matthes ML: Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst. 81:669–675. 1989.PubMed/NCBI View Article : Google Scholar

61 

Vetvicka V and Vetvickova J: Natural immunomodulators and their stimulation of immune reaction: True or false? Anticancer Res. 34:2275–2282. 2014.PubMed/NCBI

62 

Li Y, Wang Y, Wu Y, Wang B, Chen X and Xu X, Chen H, Li W and Xu X: Echinacea pupurea extracts promote murine dendritic cell maturation by activation of JNK, p38 MAPK and NF-κB pathways. Dev Comp Immunol. 73:21–26. 2017.PubMed/NCBI View Article : Google Scholar

63 

Fu A, Wang Y, Wu Y, Chen H, Zheng S, Li Y, Xu X and Li W: Echinacea purpurea extract polarizes M1 macrophages in murine bone marrow-derived macrophages through the activation of JNK. J Cell Biochem. 118:2664–2671. 2017.PubMed/NCBI View Article : Google Scholar

64 

Rondanelli M, Miccono A, Lamburghini S, Avanzato I, Riva A, Allegrini P, Faliva MA, Peroni G, Nichetti M and Perna S: Self-care for common colds: The pivotal role of vitamin D, vitamin C, zinc, and Echinacea in three main immune interactive clusters (physical barriers, innate and adaptive immunity) involved during an episode of common colds-practical advice on dosages and on the time to take these nutrients/botanicals in order to prevent or treat common colds. Evid Based Complement Alternat Med. 2018(5813095)2018.PubMed/NCBI View Article : Google Scholar

65 

Park EJ and Pezzuto JM: Botanicals in cancer chemoprevention. Cancer Metastasis Rev. 21:231–255. 2002.PubMed/NCBI View Article : Google Scholar

66 

Mao QQ, Xu XY, Cao SY, Gan RY, Corke H, Beta T and Li HB: Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe). Foods. 8(185)2019.PubMed/NCBI View Article : Google Scholar

67 

Butt MS and Sultan MT: Ginger and its health claims: Molecular aspects. Crit Rev Food Sci Nutr. 51:383–393. 2011.PubMed/NCBI View Article : Google Scholar

68 

Poles J, Karhu E, McGill M, McDaniel HR and Lewis JE: The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: A narrative review. J Clin Transl Res. 7:333–376. 2021.PubMed/NCBI

69 

Nikkhah Bodagh M, Maleki I and Hekmatdoost A: Ginger in gastrointestinal disorders: A systematic review of clinical trials. Food Sci Nutr. 7:96–108. 2018.PubMed/NCBI View Article : Google Scholar

70 

Banihani SA: Ginger and testosterone. Biomolecules. 8(119)2018.PubMed/NCBI View Article : Google Scholar

71 

Mozaffari-Khosravi H, Naderi Z, Dehghan A, Nadjarzadeh A and Fallah Huseini H: Effect of ginger supplementation on proinflammatory cytokines in older patients with osteoarthritis: outcomes of a randomized controlled clinical trial. J Nutr Gerontol Geriatr. 35:209–218. 2016.PubMed/NCBI View Article : Google Scholar

72 

Tjendraputra E, Tran VH, Liu-Brennan D, Roufogalis BD and Duke CC: Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg Chem. 29:156–163. 2001.PubMed/NCBI View Article : Google Scholar

73 

Verma SK, Singh M, Jain P and Bordia A: Protective effect of ginger, Zingiber officinale Rosc on experimental atherosclerosis in rabbits. Indian J Exp Biol. 42:736–738. 2004.PubMed/NCBI

74 

Pan MH, Hsieh MC, Kuo JM, Lai CS, Wu H, Sang S and Ho CT: 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol Nutr Food Res. 52:527–537. 2008.PubMed/NCBI View Article : Google Scholar

75 

Bahmani M, Rafieian-Kopaei M, Jeloudari M, Eftekhari Z, Delfan B, Zargaran A and Forouzan S: A review of the health effects and uses of drugs of plant licorice (Glycyrrhiza glabra L.) in Iran. Asian Pac J Trop Dis. 4 (Suppl 2):S847–S849. 2014.

76 

Wahab S, Annadurai S, Abullais SS, Das G, Ahmad W, Ahmad MF, Kandasamy G, Vasudevan R, Ali MS and Amir M: Glycyrrhiza glabra (licorice): A comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology. Plants (Basel). 10(2751)2021.PubMed/NCBI View Article : Google Scholar

77 

Ayeka PA, Bian Y, Mwitari PG, Chu X, Zhang Y, Uzayisenga R and Otachi EO: Immunomodulatory and anticancer potential of Gan cao (Glycyrrhiza uralensis Fisch.) polysaccharides by CT-26 colon carcinoma cell growth inhibition and cytokine IL-7 upregulation in vitro. BMC Complement Altern Med. 16(206)2016.PubMed/NCBI View Article : Google Scholar

78 

Jo EH, Kim SH, Ra JC, Kim SR, Cho SD, Jung JW, Yang SR, Park JS, Hwang JW, Aruoma OI, et al: Chemopreventive properties of the ethanol extract of chinese licorice (Glycyrrhiza uralensis) root: Induction of apoptosis and G1 cell cycle arrest in MCF-7 human breast cancer cells. Cancer Lett. 230:239–247. 2005.PubMed/NCBI View Article : Google Scholar

79 

Bode AM and Dong Z: Chemopreventive effects of licorice and its components. Curr Pharmacol Rep. 1:60–71. 2015.PubMed/NCBI View Article : Google Scholar

80 

Sasaki H, Suzuki N, Alshwaimi E, Xu Y, Battaglino R, Morse L and Stashenko P: 18β-glycyrrhetinic acid inhibits periodontitis via glucocorticoid-independent nuclear factor-κB inactivation in interleukin-10-deficient mice. J Periodontal Res. 45:757–763. 2010.PubMed/NCBI View Article : Google Scholar

81 

Zhou Y and Ho WS: Combination of liquiritin, isoliquiritin and isoliquirigenin induce apoptotic cell death through upregulating p53 and p21 in the A549 non-small cell lung cancer cells. Oncol Rep. 31:298–304. 2014.PubMed/NCBI View Article : Google Scholar

82 

Park SY, Kwon SJ, Lim SS, Kim JK, Lee KW and Park JHY: Licoricidin, an active compound in the hexane/ethanol extract of Glycyrrhiza uralensis, inhibits lung metastasis of 4T1 murine mammary carcinoma cells. Int J Mol Sci. 17(934)2016.PubMed/NCBI View Article : Google Scholar

83 

Seon MR, Park SY, Kwon SJ, Lim SS, Choi HJ, Park H, Lim DY, Kim JS, Lee CH, Kim J and Park JH: Hexane/ethanol extract of Glycyrrhiza uralensis and its active compound isoangustone A induce G1 cycle arrest in DU145 human prostate and 4T1 murine mammary cancer cells. J Nutr Biochem. 23:85–92. 2012.PubMed/NCBI View Article : Google Scholar

84 

Lee CK, Park KK, Lim SS, Park JHY and Chung WY: Effects of the licorice extract against tumor growth and cisplatin-induced toxicity in a mouse xenograft model of colon cancer. Biol Pharm Bull. 30:2191–2195. 2007.PubMed/NCBI View Article : Google Scholar

85 

Huo HZ, Wang B, Liang YK, Bao YY and Gu Y: Hepatoprotective and antioxidant effects of licorice extract against CCl4-induced oxidative damage in rats. Int J Mol Sci. 12:6529–6543. 2011.PubMed/NCBI View Article : Google Scholar

86 

Kim KR, Jeong CK, Park KK, Choi JH, Park JHY, Lim SS and Chung WY: Anti-inflammatory effects of licorice and roasted licorice extracts on TPA-induced acute inflammation and collagen-induced arthritis in mice. J Biomed Biotechnol. 2010(709378)2010.PubMed/NCBI View Article : Google Scholar

87 

Hobbs C: Medicinal value of lentinus edodes (Berk.) sing. (agaricomycetideae). A literature review. Int J Med Mushrooms. 2:2000.

88 

Zhang Y, Zhang M, Jiang Y, Li X, He Y, Zeng P, Guo Z, Chang Y, Luo H, Liu Y, et al: Lentinan as an immunotherapeutic for treating lung cancer: A review of 12 years clinical studies in China. J Cancer Res Clin Oncol. 144:2177–2186. 2018.PubMed/NCBI View Article : Google Scholar

89 

Mizuno T: Shiitake, lentinus edodes: Functional properties for medicinal and food purposes. Food Rev Int. 11:109–128. 1995.

90 

Wang X, Xu X and Zhang L: Thermally induced conformation transition of triple-helical lentinan in NaCl aqueous solution. J Phys Chem B. 112:10343–10351. 2008.PubMed/NCBI View Article : Google Scholar

91 

Wu X, Zheng Z, Guo T, Wang K and Zhang Y: Molecular dynamics simulation of lentinan and its interaction with the innate receptor dectin-1. Int J Biol Macromol. 171:527–538. 2021.PubMed/NCBI View Article : Google Scholar

92 

Chihara G, Hamuro J, Maeda Y, Arai Y and Fukuoka F: Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res. 30:2776–2781. 1970.PubMed/NCBI

93 

Chihara G, Hamuro J, Maeda Y, Arai Y and Fukuoka F: Antitumor polysaccharide derived chemically from natural glucan (pachyman). Nature. 225:943–944. 1970.PubMed/NCBI View Article : Google Scholar

94 

Wasser SP: Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 60:258–274. 2002.PubMed/NCBI View Article : Google Scholar

95 

Mayer S, Raulf MK and Lepenies B: C-type lectins: Their network and roles in pathogen recognition and immunity. Histochem Cell Biol. 147:223–237. 2017.PubMed/NCBI View Article : Google Scholar

96 

Brown J, O'Callaghan CA, Marshall ASJ, Gilbert RJC, Siebold C, Gordon S, Brown GD and Jones EY: Structure of the fungal beta-glucan-binding immune receptor dectin-1: Implications for function. Protein Sci. 16:1042–1052. 2007.PubMed/NCBI View Article : Google Scholar

97 

Zhang M, Zhang Y, Zhang L and Tian Q: Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China. Prog Mol Biol Transl Sci. 163:297–328. 2019.PubMed/NCBI View Article : Google Scholar

98 

Wang G, Lin W, Zhao R and Lin N: Effects of six polysaccharides extracted from plants on the immunological cells of mice. Wei Sheng Yan Jiu. 37:577–580. 2008.PubMed/NCBI(In Chinese).

99 

Kupfahl C, Geginat G and Hof H: Lentinan has a stimulatory effect on innate and adaptive immunity against murine Listeria monocytogenes infection. Int Immunopharmacol. 6:686–696. 2006.PubMed/NCBI View Article : Google Scholar

100 

Petrovska BB: Historical review of medicinal plants' usage. Pharmacogn Rev. 6:1–5. 2012.PubMed/NCBI View Article : Google Scholar

101 

Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S and Zandi K: A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014(186864)2014.PubMed/NCBI View Article : Google Scholar

102 

Kotha RR and Luthria DL: Curcumin: Biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules. 24(2930)2019.PubMed/NCBI View Article : Google Scholar

103 

Prasad S, Gupta SC, Tyagi AK and Aggarwal BB: Curcumin, a component of golden spice: From bedside to bench and back. Biotechnol Adv. 32:1053–1064. 2014.PubMed/NCBI View Article : Google Scholar

104 

Priyadarsini KI: The chemistry of curcumin: From extraction to therapeutic agent. Molecules. 19:20091–20112. 2014.PubMed/NCBI View Article : Google Scholar

105 

Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, Snyder JP, Yoon Y, Shim H, Marcus AI, et al: Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol. 12:368–377. 2012.PubMed/NCBI View Article : Google Scholar

106 

Fahey AJ, Adrian Robins R and Constantinescu CS: Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells. J Cell Mol Med. 11:1129–1137. 2007.PubMed/NCBI View Article : Google Scholar

107 

Zhou H, Beevers CS and Huang S: Targets of curcumin. Curr Drug Targets. 12:332–347. 2011.PubMed/NCBI View Article : Google Scholar

108 

Srimal RC and Dhawan BN: Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol. 25:447–452. 1973.PubMed/NCBI View Article : Google Scholar

109 

Ireson CR, Jones DJL, Orr S, Coughtrie MWH, Boocock DJ, Williams ML, Farmer PB, Steward WP and Gescher AJ: Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev. 11:105–111. 2002.PubMed/NCBI

110 

Shoba G, Joy D, Joseph T, Majeed M, Rajendran R and Srinivas PS: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64:353–356. 1998.PubMed/NCBI View Article : Google Scholar

111 

Ali M, Khan T, Fatima K, Ali QUA, Ovais M, Khalil AT, Ullah I, Raza A, Shinwari ZK and Idrees M: Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions. Phytother Res. 32:199–215. 2018.PubMed/NCBI View Article : Google Scholar

112 

Sasidharan S, Chen Y, Saravanan D, Sundram KM and Yoga Latha L: Extraction, isolation and characterization of bioactive compounds from plants' extracts. Afr J Tradit Complement Altern Med. 8:1–10. 2011.PubMed/NCBI

113 

Kaur P, Robin Mehta RG, Arora S and Singh B: Progression of conventional hepatic cell culture models to bioengineered HepG2 cells for evaluation of herbal bioactivities. Biotechnol Lett. 40:881–893. 2018.PubMed/NCBI View Article : Google Scholar

114 

Zhang Y, Wu J, Guo S, Lin W, Zhang B, Chen X, Mo H and Zhan T: The clinical efficacy and safety of the Chinese herbal medicine Astragalus (Huangqi) preparation for the treatment of acute myocardial infarction: A systematic review of randomized controlled trials. Medicine (Baltimore). 98(e15256)2019.PubMed/NCBI View Article : Google Scholar

115 

Ardjomand-Woelkart K and Bauer R: Review and assessment of medicinal safety data of orally used echinacea preparations. Planta Med. 82:17–31. 2016.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

January-December 2023
Volume 4 Issue 1

Print ISSN: 2634-7989
Online ISSN:2634-7237

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kadiyska T, Tourtourikov I, Dabchev K, Zlatarova A, Stoynev N, Hadjiolova R, Spandidos DA, Adamaki M and Zoumpourlis V: Herbs and plants in immunomodulation (Review). Int J Funct Nutr 4: 1, 2023
APA
Kadiyska, T., Tourtourikov, I., Dabchev, K., Zlatarova, A., Stoynev, N., Hadjiolova, R. ... Zoumpourlis, V. (2023). Herbs and plants in immunomodulation (Review). International Journal of Functional Nutrition, 4, 1. https://doi.org/10.3892/ijfn.2023.31
MLA
Kadiyska, T., Tourtourikov, I., Dabchev, K., Zlatarova, A., Stoynev, N., Hadjiolova, R., Spandidos, D. A., Adamaki, M., Zoumpourlis, V."Herbs and plants in immunomodulation (Review)". International Journal of Functional Nutrition 4.1 (2023): 1.
Chicago
Kadiyska, T., Tourtourikov, I., Dabchev, K., Zlatarova, A., Stoynev, N., Hadjiolova, R., Spandidos, D. A., Adamaki, M., Zoumpourlis, V."Herbs and plants in immunomodulation (Review)". International Journal of Functional Nutrition 4, no. 1 (2023): 1. https://doi.org/10.3892/ijfn.2023.31